Solat Eslami

969 total citations
67 papers, 710 citations indexed

About

Solat Eslami is a scholar working on Molecular Biology, Cancer Research and Food Science. According to data from OpenAlex, Solat Eslami has authored 67 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 31 papers in Cancer Research and 8 papers in Food Science. Recurrent topics in Solat Eslami's work include Cancer-related molecular mechanisms research (29 papers), RNA regulation and disease (12 papers) and MicroRNA in disease regulation (9 papers). Solat Eslami is often cited by papers focused on Cancer-related molecular mechanisms research (29 papers), RNA regulation and disease (12 papers) and MicroRNA in disease regulation (9 papers). Solat Eslami collaborates with scholars based in Iran, Iraq and Germany. Solat Eslami's co-authors include Mohammad Amin Hejazi, Soudeh Ghafouri‐Fard, Hajie Lotfi, Yousef Nami, Reza Vaseghi Bakhshayesh, Bashdar Mahmud Hussen, Mohammad Taheri, Hamed Mohammadi, Ramin Hosseinzadeh and Abolfazl Barzegari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Solat Eslami

60 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Solat Eslami Iran 13 353 223 121 118 79 67 710
Lijuan Bao China 16 501 1.4× 188 0.8× 137 1.1× 107 0.9× 62 0.8× 43 1.0k
Emília Hijová Slovakia 16 466 1.3× 242 1.1× 50 0.4× 290 2.5× 26 0.3× 47 877
Zeinab Faghfoori Iran 19 310 0.9× 188 0.8× 41 0.3× 155 1.3× 25 0.3× 36 870
Nana Ma China 20 387 1.1× 89 0.4× 87 0.7× 130 1.1× 18 0.2× 54 996
Cuicui Duan China 17 481 1.4× 279 1.3× 48 0.4× 131 1.1× 12 0.2× 55 954
Kim A.T. Verheijden Netherlands 13 210 0.6× 85 0.4× 40 0.3× 94 0.8× 29 0.4× 18 629
Chengyu Huang China 14 290 0.8× 184 0.8× 34 0.3× 172 1.5× 24 0.3× 65 724
Hui Yan Denmark 18 414 1.2× 94 0.4× 48 0.4× 180 1.5× 23 0.3× 36 776
Guangjun Chang China 21 483 1.4× 90 0.4× 126 1.0× 167 1.4× 20 0.3× 68 1.3k
Karolina Kowalska Poland 18 350 1.0× 74 0.3× 123 1.0× 60 0.5× 49 0.6× 50 899

Countries citing papers authored by Solat Eslami

Since Specialization
Citations

This map shows the geographic impact of Solat Eslami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solat Eslami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solat Eslami more than expected).

Fields of papers citing papers by Solat Eslami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Solat Eslami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solat Eslami. The network helps show where Solat Eslami may publish in the future.

Co-authorship network of co-authors of Solat Eslami

This figure shows the co-authorship network connecting the top 25 collaborators of Solat Eslami. A scholar is included among the top collaborators of Solat Eslami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Solat Eslami. Solat Eslami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asad, Sedigheh, et al.. (2025). Cloning, Expression, Characterization and in silico studies of l-asparaginase from Vibrio sp. (GBPx3). Biochimie. 233. 122–131. 1 indexed citations
2.
Ghasemian, Majid, et al.. (2025). Temozolomide resistance in glioblastoma: a non-coding RNA viewpoint. SHILAP Revista de lepidopterología. 15. 100158–100158.
3.
Gargari, Soraya Saleh, et al.. (2024). Performance of cell free DNA as a screening tool based on the results of first trimester screening. Molecular Cytogenetics. 17(1). 33–33.
5.
Ghafouri‐Fard, Soudeh, Bashdar Mahmud Hussen, & Solat Eslami. (2024). Identification of miR-125a and miR-106b signature as a potential diagnostic biomarker in breast cancer tissues. Pathology - Research and Practice. 256. 155277–155277. 1 indexed citations
6.
Jamali, Elena, et al.. (2024). Integrated bioinformatics approaches and expression assays identified new markers in pituitary adenomas. Pathology - Research and Practice. 255. 155193–155193. 1 indexed citations
7.
Hussen, Bashdar Mahmud, et al.. (2023). Expression analysis of Rho GTPase-related lncRNAs in breast cancer. Pathology - Research and Practice. 244. 154429–154429. 6 indexed citations
8.
Taheri, Mohammad, et al.. (2023). Assessment of expression of calcium signaling related lncRNAs in epilepsy. Scientific Reports. 13(1). 17993–17993. 5 indexed citations
9.
Taheri, Mohammad, et al.. (2023). Upregulation of MAPKAPK5‐AS1, PXN‐AS1 and URB1‐AS1 lncRNAs in non‐functioning pituitary adenoma. Journal of Cellular and Molecular Medicine. 27(11). 1550–1556. 5 indexed citations
10.
Taheri, Mohammad, et al.. (2023). Expression of cAMP and oxidative phosphorylation‐related lncRNAs in non‐functioning pituitary adenomas. Journal of Cellular and Molecular Medicine. 27(24). 4195–4201. 3 indexed citations
11.
Hussen, Bashdar Mahmud, et al.. (2023). Association between ANRIL polymorphisms and risk of obsessive-compulsive disorder. Heliyon. 9(3). e14081–e14081. 4 indexed citations
12.
Ghafouri‐Fard, Soudeh, et al.. (2023). Expression analysis of PPAR-related lncRNAs in breast cancer. Pathology - Research and Practice. 251. 154844–154844. 3 indexed citations
13.
Ghafouri‐Fard, Soudeh, Farzaneh Abbasi, Bashdar Mahmud Hussen, et al.. (2023). Dysregulation of PVT1 and NEAT1 lncRNAs in pituitary adenomas. Pathology - Research and Practice. 248. 154573–154573. 7 indexed citations
14.
Ghafouri‐Fard, Soudeh, Mahdi Gholipour, Solat Eslami, et al.. (2023). Abnormal expression of MAPK14-related lncRNAs in the peripheral blood of patients with multiple sclerosis. Non-coding RNA Research. 8(3). 335–339. 7 indexed citations
15.
Gholipour, Mahdi, Solat Eslami, Bashdar Mahmud Hussen, et al.. (2022). Expression analysis of mTOR-associated lncRNAs in multiple sclerosis. Metabolic Brain Disease. 37(6). 2061–2066. 5 indexed citations
16.
Gholipour, Mahdi, Bashdar Mahmud Hussen, Atefe Abak, et al.. (2022). Expression of NF-κB-associated lncRNAs in different types of migraine. Acta Neurologica Belgica. 123(5). 1823–1831. 4 indexed citations
17.
Gholipour, Mahdi, et al.. (2022). Expression analysis of vitamin D receptor and its related long non-coding RNAs in peripheral blood of patients with Parkinson's disease. Molecular Biology Reports. 49(7). 5911–5917. 1 indexed citations
18.
Taheri, Mohammad, Mahdi Gholipour, Bashdar Mahmud Hussen, et al.. (2022). Analysis of expression of regulatory T cell related lncRNAs in inflammatory demyelinating polyneuropathies. International Immunopharmacology. 112. 109188–109188. 2 indexed citations
19.
Kadkhoda, Sepideh, Bashdar Mahmud Hussen, Solat Eslami, & Soudeh Ghafouri‐Fard. (2022). A review on the role of miRNA-324 in various diseases. Frontiers in Genetics. 13. 950162–950162. 6 indexed citations
20.
Barez, Shirin, et al.. (2011). Common mutations in exon 10 of RET proto-oncogene in patients with medullar thyroid carcinoma. Trauma Monthly. 16(2). 73–78. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026